Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma

NCT01545635 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT01545635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01545635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Lead sponsor
Medical University Innsbruck
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2012
Completion date
February 29, 2016
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major trauma